Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- Health Spending
- Health Spend Management
- High-Deductible Health Plans
- Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Pharmacy Benefit Managers (PBMs)
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Display Only
Showing 1216 Results
Dr. Dubois to Lead Discussions on Rapid Learning Health Care Systems and Need for New Evidence @ AcademyHealth’s EDM Forum & Annual Research Meeting
With more physicians utilizing electronic health records (EHRs), the United States’ evidence base is rapidly growing. EHRs and their related data infrastructure will make it possible to collect and…
#TBT: Ethnic Disparities in the Burden and Treatment of Asthma
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
NPC to Discuss Role of Pharmaceuticals, Applying Real-World Evidence at ISPOR Annual Meeting
NPC invites you to join us for a pre-conference symposium, panel presentations and poster sessions on issues ranging from the role of pharmaceuticals in accountable care organizations to the…
The Good, the Bad and the Different
“The Good, the Bad and the Different,” the title of a recent educational program and research project by the University of Arizona School of Pharmacy in collaboration with and sponsored by the…
The Good, the Bad, and the Different: A Primer on Aspects of Heterogeneity of Treatment Effects
The concept of heterogeneity is explained and further explored via four articles published in the June 2014 issue of the Journal of Managed Care & Specialty Pharmacy: The Good, the Bad, and the…
What Stakeholders Think About CER & Other Questions You Might Have Missed
We had a lively conversation on May 19 during our webinar, “Comparative Effectiveness Research and the Environment for Decision-making.” You can watch the archived webinar, featuring NPC President…
2014 Comparative Effectiveness Research and the Environment for Health Care Decision-Making
Through this annual survey, NPC has been able to track changes in which organizations are perceived as influential in areas such as prioritizing, funding, conducting and monitoring CER, as well as…
#TBT Takes a CER Snapshot: How Stakeholder Perceptions Have Changed Over Time
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
NPC @ HIX Summit: How Rx and Pharma Will Participate in the Exchanges
One of the most pressing issues in the implementation of the Affordable Care Act (ACA) is whether the state health insurance exchanges, or marketplaces, will be effective in achieving their primary…
Coming Attraction: You Get What You Pay For: Will ACOs Underuse Drugs?
Exactly one month from today, the National Pharmaceutical Council will host a pre-conference educational symposium on one of the most buzzed-about topics in health care—accountable care organizations…
NPC Webinar to Examine the State of Comparative Effectiveness Research & Health Care Decision-Making
Which organizations are considered key players in funding, monitoring, and developing standards for comparative effectiveness research (CER)? Do health care stakeholders think that CER is already…
#TBT: Making Informed Decisions: What Kinds of Studies Will PCORnet Undertake?
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
#TBT: Medicaid Expansion & Historical Data
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
4/8 Webinar on CER Collaborative: Tools You Can Use
The CER Collaborative--a group formed by the Academy of Managed Care Pharmacy (AMCP), the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the National Pharmaceutical…